Ronald Oudiz, MD, FACP, FACC, FCCP, provides clinical insights on the evolving treatment landscape for patients with pulmonary arterial hypertension, focusing onemerging therapies and integrating them into clinical practice.
EP. 5: Breaking Down the PAH Cost Burden
May 6th 2024Marius Hoeper, MD, discusses the direct medical costs and indirect socioeconomic costs associated with the treatment of pulmonary arterial hypertension (PAH), including hospitalizations, outpatient care, and patient productivity and quality of life.
Watch
2 Commerce Drive
Cranbury, NJ 08512